Search results
Oprah hospitalized after 'stuff was coming out of both ends,' Gayle King (over)shares
Los Angeles Times· 2 days agoOprah Winfrey has been hospitalized, according to her best friend and journalist Gayle King, who...
Can Taping Your Mouth Shut at Night Improve Your Sleep?
Gizmodo· 7 days agoOne of the latest health trends on TikTok and other social media is mouth taping, which is exactly what it sounds like. Sleep apnea happens when our ability to breathe is cut off during sleep ...
Researchers Describe Cases of Pancreatitis With Tirzepatide
Medscape· 4 days agoIn one case, a 64-year-old patient died. Clinicians and patients should be aware of this complication, especially as more patients take this type of antidiabetic and weight loss medication, researchers said.
Ohio leads country in percentage increase of strokes: What's causing it
Journal-News, Hamilton, Ohio via Yahoo News· 3 days agoJun. 11—Mickey Stewart had a stroke in November that changed his life immediately. "I couldn't walk. I couldn't speak. I couldn't use my arm. I couldn't do math. I couldn't do anything," the ...
Idaho depends on attracting and retaining rural physicians
Idaho Capital Sun via Yahoo News· 3 days agoRecruiting and retaining primary care physicians in rural Idaho has an array of challenges. Rising...
Biophytis Announces the Successful Industrial Transfer of BIO101
Digital Journal· 2 days agoBIO101 (20-hydroxyecdysone), our lead drug candidate, is a small molecule in development for muscular (sarcopenia, phase 3 ready and Duchenne muscular dystrophy), respiratory (Covid-19 phase ...
Psoriasis After COVID-19: Is There a Connection?
Healthline· 7 days agoA few studies suggest some people with psoriasis may experience flares after getting COVID-19 or the vaccine. Psoriasis is a common autoimmune condition...
Doctors in Gaza Reuse Medical Implants Cut Out of Victims
The Daily Beast· 4 days agoSupplies are now so short that doctors working in Gaza tell The Daily Beast they have been forced to...
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
The Pilot News· 6 days agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational use of tirzepatide ...
Boehringer Ingelheim's survodutide shows breakthrough improvement in liver fibrosis with no...
Benzinga· 7 days agoNews builds on previously announced primary endpoint, which showed up to 83.0% of adults achieved statistically significant improvement in metabolic dysfunction-associated steatohepatitis (MASH) versus placebo